Search for: "U.S. v. Hamel*"
Results 1 - 17
of 17
Sorted by Relevance
|
Sort by Date
4 Jul 2008, 3:50 pm
Wright, 2008 U.S. [read post]
11 Mar 2008, 5:17 am
Hamel v. [read post]
10 Aug 2020, 2:24 am
A supreme flouting of the military and industrial contexts can be found in DeVries v. [read post]
22 Mar 2017, 4:42 am
In Microsoft v. [read post]
27 Oct 2011, 5:02 am
Briscoe v. [read post]
23 Jul 2009, 9:04 am
Cirrincione v. [read post]
22 Sep 2011, 10:52 am
The investigation was led by the U.S. [read post]
22 Sep 2011, 10:52 am
The investigation was led by the U.S. [read post]
27 Mar 2018, 7:54 am
Under Massachusetts law, as held in Falvey v. [read post]
27 Mar 2018, 7:54 am
Under Massachusetts law, as held in Falvey v. [read post]
30 May 2022, 9:00 pm
” Id.This guidance potentially conflicts with that of the U.S. [read post]
22 Feb 2012, 12:46 am
K-V’s announcement of the termination in an 8-K triggered an investigation by the local U.S. attorney, and regulatory actions by the FDA and the Department of Health and Human Services. [read post]
4 Dec 2023, 2:49 pm
Kastenberg, Goldwater v. [read post]
26 Feb 2022, 6:53 pm
In a seminal 1977 discrimination case, Casteneda v. [read post]
9 Mar 2015, 7:48 am
., MDL No. 2342; 12-md-2342, 2014 U.S. [read post]
19 Jun 2022, 5:05 pm
” Id. at 430 U.S. 482, 496 n.17 (1977). [read post]
13 Apr 2024, 3:33 pm
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
